Showing results (2091-2100 of 2,162) with videos related to

Sort By:
Pageof 217
Haematologica|November 8, 2011
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorAlejandra Carvajal-Cuenca, Luz F Sua, Nhora M Silva, et al.
International Immunopharmacology|May 4, 2004
Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2Jing Li, Kathy N Tomkinson, Xiang-Yang Tan, et al.
Medicine and Science in Sports and Exercise|October 1, 2024
The Efficacy of Blood Flow Restriction Training to Improve Quadriceps Muscle Function after Anterior Cruciate Ligament ReconstructionLauren N Erickson, Meredith K Owen, Kelsey R Casadonte, et al.
JAMA Network Open|April 7, 2025
Mindfulness vs Cognitive Behavioral Therapy for Chronic Low Back Pain Treated With Opioids: A Randomized Clinical TrialAleksandra E Zgierska, Robert R Edwards, Bruce Barrett, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutatedTanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
PLOS Global Public Health|July 9, 2025
Iron deficiency anaemia in mothers and infants with high inflammatory burden: Prevalence and profile in a South African birth cohortJessica E Ringshaw, Michal R Zieff, Sadeeka Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2018
Ocean convergence and the dispersion of flotsamEric A D'Asaro, Andrey Y Shcherbina, Jody M Klymak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 16, 2015
Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short versionR N Werner, E Stockfleth, S M Connolly, et al.
Cancer Discovery|August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast CancerJames T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
Pageof 217